Skip to main content

OHC Provides Tri-State Patients with Access to Growing Number of Immunotherapy Clinical Trials

ncer accounts for 1,500 deaths each day in the United States. For decades, surgery, radiation and chemotherapy have been the predominant treatments against this disease. Fortunately, clinical trials over the last few years have shown that harnessing the body’s immune response and ability to fend off harmful bacteria and viruses through immunotherapies is a promising treatment option.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2023 Esophageal Cancer Education Foundation- by domino